Neuroimaging in vascular cognitive impairment: a state-of-the-art review

[1]  W. M. van der Flier,et al.  Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT. , 2009, Radiology.

[2]  D. Leys,et al.  The incidence of post-mortem neurodegenerative and cerebrovascular pathology in mixed dementia , 2016, Journal of the Neurological Sciences.

[3]  O Sabri,et al.  Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy. , 1999, Stroke.

[4]  P. Gorelick,et al.  Key Neuroanatomical Structures for Post-Stroke Cognitive Impairment , 2012, Current Neurology and Neuroscience Reports.

[5]  M. O’Sullivan.  Diffusion in Chronic Stroke and Small Vessel Disease , 2010 .

[6]  K. Herholz,et al.  Cerebral acetylcholine esterase activity in mild cognitive impairment , 2005, Neuroreport.

[7]  Thomas R. Knösche,et al.  White matter integrity, fiber count, and other fallacies: The do's and don'ts of diffusion MRI , 2013, NeuroImage.

[8]  L. Defebvre,et al.  The Significance of Cortical Cerebellar Microbleeds and Microinfarcts in Neurodegenerative and Cerebrovascular Diseases , 2015, Cerebrovascular Diseases.

[9]  Derek K. Jones.  Studying connections in the living human brain with diffusion MRI , 2008, Cortex.

[10]  V. Hachinski,et al.  Interaction Between a Rat Model of Cerebral Ischemia and &bgr;-Amyloid Toxicity: Inflammatory Responses , 2005, Stroke.

[11]  Frederik Barkhof,et al.  Operational Definitions for the NINDS-AIREN Criteria for Vascular Dementia: An Interobserver Study , 2003, Stroke.

[12]  J. Trojanowski,et al.  Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls , 2013, Neuron.

[13]  Chris A Clark,et al.  Multimodal MRI in Cerebral Small Vessel Disease: Its Relationship With Cognition and Sensitivity to Change Over Time , 2008, Stroke.

[14]  Wang Min,et al.  Leuko araiosis , 2006 .

[15]  D. Leys,et al.  Superficial Siderosis of the Central Nervous System: A Post-Mortem 7.0-Tesla Magnetic Resonance Imaging Study with Neuropathological Correlates , 2013, Cerebrovascular Diseases.

[16]  D. Leys,et al.  Topography of Cortical Microbleeds in Alzheimer's Disease with and without Cerebral Amyloid Angiopathy: A Post-Mortem 7.0-Tesla MRI Study. , 2015, Aging and disease.

[17]  M. Brainin,et al.  Post‐stroke cognitive decline: an update and perspectives for clinical research , 2015, European journal of neurology.

[18]  D. Leys,et al.  Comparison of 7.0-T T2*-Magnetic Resonance Imaging of Cerebral Bleeds in Post-Mortem Brain Sections of Alzheimer Patients with Their Neuropathological Correlates , 2011, Cerebrovascular Diseases.

[19]  Jeffrey A. James,et al.  Frequent amyloid deposition without significant cognitive impairment among the elderly. , 2008, Archives of neurology.

[20]  S. Black,et al.  Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[21]  C. Beaulieu,et al.  Water diffusion in the giant axon of the squid: Implications for diffusion‐weighted MRI of the nervous system , 1994, Magnetic resonance in medicine.

[22]  Owen Carmichael,et al.  White Matter Hyperintensities and Their Penumbra Lie Along a Continuum of Injury in the Aging Brain , 2014, Stroke.

[23]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[24]  K Herholz,et al.  Severity of vascular dementia is related to volume of metabolically impaired tissue. , 1992, Archives of neurology.

[25]  G C Roman,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[26]  W. Brooks,et al.  1H-MRS differentiates white matter hyperintensities in subcortical arteriosclerotic encephalopathy from those in normal elderly. , 1997, Stroke.

[27]  H. Chui,et al.  Subcortical ischaemic vascular dementia , 2002, The Lancet Neurology.

[28]  Howard J. Rosen,et al.  Neuroimaging in Dementia , 2011, Neurotherapeutics.

[29]  P. Koudstaal,et al.  Silent brain infarcts: a systematic review , 2007, The Lancet Neurology.

[30]  H. Koennecke.  Cerebral microbleeds on MRI , 2006, Neurology.

[31]  P. Basser,et al.  Toward a quantitative assessment of diffusion anisotropy , 1996, Magnetic resonance in medicine.

[32]  J. O'Brien,et al.  Imaging of neuroinflammation in dementia: a review , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[33]  Masafumi Ihara,et al.  Emerging Evidence for Pathogenesis of Sporadic Cerebral Small Vessel Disease , 2016 .

[34]  Peter R Luijten,et al.  In Vivo Detection of Cerebral Cortical Microinfarcts with High-Resolution 7T MRI , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  B L Miller,et al.  Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect. , 1992, Archives of neurology.

[36]  James A. Mortimer,et al.  Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply , 1997 .

[37]  E. Ross.  Association , 1886, American Journal of Sociology.

[38]  Jean-François Mangin,et al.  Monitoring Disease Progression in CADASIL With Diffusion Magnetic Resonance Imaging: A Study With Whole Brain Histogram Analysis , 2002, Stroke.

[39]  M. O’Sullivan,et al.  Damage within a network of white matter regions underlies executive dysfunction in CADASIL , 2005, Neurology.

[40]  G. B. Pike,et al.  Changes in Callosal Motor Fiber Integrity after Subcortical Stroke of the Pyramidal Tract , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[41]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[42]  D. Leys,et al.  The Topography of Cortical Microinfarcts in Neurodegenerative Diseases and in Vascular Dementia: A Postmortem 7.0-Tesla Magnetic Resonance Imaging Study , 2016, European Neurology.

[43]  D. Leys,et al.  Iron deposits in post‐mortem brains of patients with neurodegenerative and cerebrovascular diseases: a semi‐quantitative 7.0 T magnetic resonance imaging study , 2014, European journal of neurology.

[44]  Alexander Leemans,et al.  Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy. , 2015, Brain : a journal of neurology.

[45]  V. Hachinski,et al.  Prevalence and outcomes of vascular cognitive impairment , 2000, Neurology.

[46]  David H. Laidlaw,et al.  Quantitative tractography metrics of white matter integrity in diffusion-tensor MRI , 2008, NeuroImage.

[47]  et al.,et al.  Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET , 2002, NeuroImage.

[48]  Michel Goedert,et al.  Tau pathology and neurodegeneration , 2013, The Lancet Neurology.

[49]  J. Jeret.  Prevalence and severity of microbleeds in a memory clinic setting , 2007, Neurology.

[50]  David S Knopman,et al.  Vascular dementia in a population-based autopsy study. , 2003, Archives of neurology.

[51]  D. Benson,et al.  The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. , 1983, Archives of neurology.

[52]  L. Ferrucci,et al.  Memory decline shows stronger associations with estimated spatial patterns of amyloid deposition progression than total amyloid burden , 2013, Neurobiology of Aging.

[53]  Derek K. Jones,et al.  Evidence for cortical “disconnection” as a mechanism of age-related cognitive decline , 2001, Neurology.

[54]  Derek K. Jones,et al.  CSF contamination contributes to apparent microstructural alterations in mild cognitive impairment , 2014, NeuroImage.

[55]  Nils Peters,et al.  Diffusion Magnetic Resonance Histograms as a Surrogate Marker and Predictor of Disease Progression in CADASIL: A Two-Year Follow-Up Study , 2005, Stroke.

[56]  R. Hilker,et al.  Dementia in Parkinson disease , 2005, Neurology.

[57]  J. Wardlaw,et al.  Post-Mortem MR Brain Imaging Comparison with Macro- and Histopathology: Useful, Important and Underused , 2011, Cerebrovascular Diseases.

[58]  I. Deary,et al.  Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities , 2014, Neurology.

[59]  A. W. Chung,et al.  Structural network efficiency is associated with cognitive impairment in small-vessel disease , 2014, Neurology.

[60]  M. Maeda,et al.  In vivo Detection of Cortical Microinfarcts on Ultrahigh‐Field MRI , 2013, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[61]  Clifford Qualls,et al.  Blood–Brain Barrier Permeability Abnormalities in Vascular Cognitive Impairment , 2011, Stroke.

[62]  K. Jellinger,et al.  The enigma of vascular cognitive disorder and vascular dementia , 2007, Acta Neuropathologica.

[63]  Ralf Schirrmacher,et al.  The Temporal Dynamics of Poststroke Neuroinflammation: A Longitudinal Diffusion Tensor Imaging–Guided PET Study with 11C-PK11195 in Acute Subcortical Stroke , 2010, The Journal of Nuclear Medicine.

[64]  Arvind Caprihan,et al.  Long-Term Blood–Brain Barrier Permeability Changes in Binswanger Disease , 2015, Stroke.

[65]  岩本俊彦.  Leuko-araiosis と血管性痴呆 , 1996 .

[66]  K. Haaland,et al.  Clinical significance of MRI white matter lesions in the elderly , 1989, Neurology.

[67]  Karl Herholz,et al.  Clinical amyloid imaging in Alzheimer's disease , 2011, The Lancet Neurology.

[68]  Noth,et al.  Dynamics of microglial activation in the spinal cord after cerebral infarction are revealed by expression of MHC class II antigen , 1998, Neuropathology and applied neurobiology.

[69]  N. Bohnen,et al.  Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature , 2012, The Journal of Nuclear Medicine.

[70]  P. Pasqualetti,et al.  Cortical Ischemic Lesion Burden Measured by DIR Is Related to Carotid Artery Disease Severity , 2014, Cerebrovascular Diseases.

[71]  C. Wheeler-Kingshott,et al.  About “axial” and “radial” diffusivities , 2009, Magnetic resonance in medicine.

[72]  George Fein,et al.  Proton magnetic resonance spectroscopy of human brain: Applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities , 1992, Magnetic resonance in medicine.

[73]  S. Pendlebury.  Dementia in Patients Hospitalized with Stroke: Rates, Time Course, and Clinico-Pathologic Factors , 2012, International journal of stroke : official journal of the International Stroke Society.

[74]  W. Heiss,et al.  PET imaging in the differential diagnosis of vascular dementia , 2012, Journal of the Neurological Sciences.

[75]  C. Rowe,et al.  Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[76]  A. Thiel,et al.  Imaging of Microglia Activation in Stroke , 2011, Stroke.

[77]  Reinhold Schmidt,et al.  Consensus statement for diagnosis of subcortical small vessel disease , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[78]  D. Leys,et al.  Detection of microbleeds in post‐mortem brains of patients with frontotemporal lobar degeneration: a 7.0‐Tesla magnetic resonance imaging study with neuropathological correlates , 2012, European journal of neurology.

[79]  A. Thiel,et al.  Amyloid burden, neuroinflammation, and links to cognitive decline after ischemic stroke. , 2014, Stroke.

[80]  A. Wallin,et al.  Multimodal Markers of Inflammation in the Subcortical Ischemic Vascular Disease Type of Vascular Cognitive Impairment , 2014, Stroke.

[81]  Paul M Thompson,et al.  Current and future uses of neuroimaging for cognitively impaired patients , 2008, The Lancet Neurology.

[82]  P. Scheltens,et al.  A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.

[83]  G. Román,et al.  Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. , 1987, JAMA.

[84]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[85]  D. Leys,et al.  Prevalence of small cerebral bleeds in patients with a neurodegenerative dementia: A neuropathological study , 2011, Journal of the Neurological Sciences.

[86]  A. Korczyn.  Mixed Dementia—the Most Common Cause of Dementia , 2002, Annals of the New York Academy of Sciences.

[87]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[88]  H S Markus,et al.  Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[89]  E. Bramon,et al.  Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies , 2014, BMC Psychiatry.

[90]  V. Hachinski,et al.  Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. , 2000, Neurology.

[91]  David G. Norris,et al.  Microstructural integrity of the cingulum is related to verbal memory performance in elderly with cerebral small vessel disease The RUN DMC study , 2013, NeuroImage.

[92]  D. Leys,et al.  Post-mortem 7.0-tesla magnetic resonance study of cortical microinfarcts in neurodegenerative diseases and vascular dementia with neuropathological correlates , 2014, Journal of the Neurological Sciences.